JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5476
Redwire
RDW
$2.61B
| $46K | ﹤0.01% |
15,099
+2,160
| +17% | +$6.37K |
2022 Q2
3 quarters
|
|
5477
Urban One Class D
UONEK
$15.9M
| $46K | ﹤0.01% |
828
+107
| +15% | +$5.31K |
2022 Q2
3 quarters
|
|
|
BSJN
5478
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
| $46K | ﹤0.01% |
1,967
+1,952
| +13,013% | +$45.9K |
2022 Q4
1 quarter
|
|
5479
Akebia Therapeutics
AKBA
$252M
| $45K | ﹤0.01% |
81,547
+77,503
| +1,916% | +$59.2K |
2017 Q4
21 quarters
|
|
|
MITT
5480
TPG Mortgage Investment Trust
MITT
$179M
| $45K | ﹤0.01% |
7,854
+7,852
| +392,600% | +$47.5K |
2015 Q4
29 quarters
|
|
5481
Rigetti Computing
RGTI
$5.06B
| $45K | ﹤0.01% |
62,649
+5,368
| +9% | +$4.36K |
2022 Q2
3 quarters
|
|
5482
ProShares Short SmallCap600
SBB
$3.81M
| $45K | ﹤0.01% |
1,250
| – | – |
2022 Q2
3 quarters
|
|
|
IVAC
5483
DELISTED
Intevac Inc
IVAC
| $45K | ﹤0.01% |
+6,175
| New | +$43.4K |
2023 Q1
0 quarters
|
|
|
AMYT
5484
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $45K | ﹤0.01% |
3,073
+3,071
| +153,550% | +$43.4K |
2021 Q1
8 quarters
|
|
5485
FT Vest Gold Strategy Target Income ETF
IGLD
$603M
| $45K | ﹤0.01% |
+2,276
| New | +$44.1K |
2023 Q1
0 quarters
|
|
5486
AllianzIM U.S. Equity Buffer10 Apr ETF
APRT
$47.2M
| $44.3K | ﹤0.01% |
+1,500
| New | +$42.8K |
2023 Q1
0 quarters
|
|
5487
AllianzIM U.S. Equity Buffer10 Oct ETF
OCTT
$56.2M
| $44.2K | ﹤0.01% |
+1,470
| New | +$43.1K |
2023 Q1
0 quarters
|
|
5488
Quadratic Deflation ETF
BNDD
$12.7M
| $44K | ﹤0.01% |
+351
| New | +$43.8K |
2023 Q1
0 quarters
|
|
5489
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$414M
| $44K | ﹤0.01% |
+597
| New | +$45K |
2023 Q1
0 quarters
|
|
|
EVN
5490
Eaton Vance Municipal Income Trust
EVN
$362M
| $44K | ﹤0.01% |
+4,312
| New | +$44.3K |
2023 Q1
0 quarters
|
|
|
NINE
5491
PUT
DELISTED
Nine Energy Service
NINE
| $44K | ﹤0.01% |
+8,000
| New | +$82.7K |
2023 Q1
0 quarters
|
|
5492
FreightCar America
RAIL
$222M
| $44K | ﹤0.01% |
13,951
-3,588
| -20% | -$12.4K |
2022 Q2
3 quarters
|
|
5493
VanEck Short Muni ETF
SMB
$321M
| $44K | ﹤0.01% |
+2,579
| New | +$43.6K |
2023 Q1
0 quarters
|
|
|
TDF
5494
Templeton Dragon Fund
TDF
$241M
| $44K | ﹤0.01% |
+4,160
| New | +$46.2K |
2023 Q1
0 quarters
|
|
|
FDEU
5495
DELISTED
First Trust Dynamic Europe Equity Income Fund
FDEU
| $44K | ﹤0.01% |
3,446
+3,302
| +2,293% | +$39.8K |
2022 Q4
1 quarter
|
|
5496
iShares Global Industrials ETF
EXI
$1.46B
| $43.7K | ﹤0.01% |
+383
| New | +$42.8K |
2023 Q1
0 quarters
|
|
5497
Viking Therapeutics
VKTX
$3.68B
| $43.7K | ﹤0.01% |
2,638
+2,140
| +430% | +$22.1K |
2018 Q2
19 quarters
|
|
5498
iShares Currency Hedged MSCI Emerging Markets
HEEM
$306M
| $43.4K | ﹤0.01% |
1,805
-1,714
| -49% | -$41.4K |
2022 Q4
1 quarter
|
|
5499
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.62B
| $43.2K | ﹤0.01% |
1,640
+527
| +47% | +$13.7K |
2022 Q2
3 quarters
|
|
5500
CALL
Equinor
EQNR
$100B
| $43K | ﹤0.01% |
+1,500
| New | +$45.3K |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.